CDRI prepared dose to tackle stubborn tuberculosis
The Central Drug Research Institute (CDRI), Lucknow, has developed four synthetic compounds with presumed strong therapeutic activity against multi-drug resistant (MDR) TB. The institute would
The Central Drug Research Institute (CDRI), Lucknow, has developed four synthetic compounds with presumed strong therapeutic activity against multi-drug resistant (MDR) TB. The institute would